Successful drugs made in Darmstadt

Merck manufactures several of its most successful drugs at the Darmstadt site. These include Erbitux®, Concor®, Euthyrox® and Nasivin®. These products have different phamaceutical dosage forms (solid or liquid), which represent the wide variety of drug production in Darmstadt.

Erbitux® is a monoclonal antibody targeting the epidermal growth factor receptor (EGFR) of tumors. It is currently approved for metastatic colorectal cancer and for head and neck tumor indications. Sterile drug filling and drug finishing for global supply are performed in Darmstadt.

Concor®  is a beta-blocker that is successfully used to treat high blood pressure and coronary heart disease. Owing to its excellent tolerability and efficacy, Concor® is the most widely used beta-blocker in Europe. Concor® is manufactured and packaged in Darmstadt and then shipped around the world.

Euthyrox® (active ingredient levothyroxine), which ranks among the most successful thyroid medications in the world, is also produced in Darmstadt. It is used to treat hypothyroidism.

In addition to prescription drugs, the cold remedy Nasivin® is also produced in Darmstadt. It is one of the best-known over-the-counter products from Merck. This highly popular cold treatment is available to patients of all ages.

With its “solids building”, which was completed in 2002, the Darmstadt site is also Merck’s largest pharmaceutical manufacturing location worldwide. The company manufactures around 100 different products in tablet form here.

All drugs manufactured in Darmstadt meet the most stringent international quality standards. This ensures that the drugs supplied to patients are of the highest purity, and consequently efficacy and tolerability.